Chronic Inflammatory Demyelinating Polyneuropathy: Current Therapies and Emerging Horizons
In this MEDtalk, Anders Svenningsson, MD, PhD, Professor at the Karolinska Institute in Sweden, discusses current treatment strategies for chronic inflammatory demyelinating polyneuropathy (CIDP), with considerations for both younger and older patient populations. He also shares his perspective on emerging therapies and offers insights into the future direction of CIDP management.
Få tilgang
Hvis du er lege, sykepleier eller annen helsepersonell, kan du få tilgang til hele artikkelen ved å opprette en profil på BestPractice Nordic.
- Få tilgang
- Hvis du allerede har en profil: Logg in
